Biggest gainers and losers for July 13-17, 2026
AI Briefing
- • Biogen's stock surged 14.2% after FDA approval for new Alzheimer's treatment.
- • Moderna's stock dropped 10.3% due to production delays and regulatory issues.
- • Gilead's stock rose 7.5% after announcing a new HIV treatment trial.
Context
The top 10 biopharma stock gainers and losers for the week of July 13-17, 2026, have been identified.
The performance of these biopharma stocks is significant for investors and industry observers who track the sector's weekly gains and losses.
Advertisement